Results 91 to 100 of about 50,426 (246)

Childhood alopecia areata: What treatment works best? [PDF]

open access: yes, 2011
There are no validated effective treatments for alopecia areata (AA). Topical immunotherapy (squaric acid dibutylester [SADBE] and diphenylcyclopropenone [DPCP]) induces the most significant short-term hair regrowth in children with severe AA (strength ...
Haynes, James W.   +2 more
core  

Acne exacerbation after tofacitinib treatment for alopecia areata

open access: yesDermatology Reports, 2021
The major discovery of the novel therapeutic Janus kinase (JAK) inhibitors has been implicated in several dermatological diseases. Recently, studies have shown the efficacy and encouraging results of oral JAK inhibitors as a treatment for alopecia areata
Sawsan Alharthi   +2 more
doaj   +1 more source

Bullous hemorrhagic lichen sclerosus of the breast: a report of two cases and review of the literature [PDF]

open access: yes, 2019
Lichen sclerosus (LS) is a chronic dermatologic condition characterized by atrophic porcelain-appearing plaques that can cause intense discomfort and eventually lead to destruction of local architecture.
Kroger, Kathleen T   +3 more
core  

Alopecia areata: a new treatment plan [PDF]

open access: yes, 2011
Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles. Unfortunately, none of these agents is curative or preventive.
Alsantali, Adel
core   +3 more sources

Treatments for alopecia areata: a network meta-analysis [PDF]

open access: yes, 2020
Acknowledgement: “This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2020, Issue 9. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane ...
Arevalo-Rodriguez, I   +10 more
core   +1 more source

Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata

open access: yesPhotodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 1, January 2026.
ABSTRACT Background/Purpose Alopecia areata (AA) is a non‐scarring autoimmune hair loss disorder. Although phototherapy has been utilized to treat AA, its efficacy and mechanisms remain unclear. This study aimed to evaluate the effectiveness of phototherapy in AA and determine whether treatment outcomes vary depending on patient characteristics ...
Aya Yamamoto   +6 more
wiley   +1 more source

Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient

open access: yesIndian Journal of Rheumatology, 2019
Azathioprine, an analog of mercaptopurine, is used for various inflammatory/autoimmune diseases in diverse fields such as rheumatology, ophthalmology, gastroenterology, and neurology.
Debashish Mishra   +4 more
doaj   +1 more source

Alopecia Areata [PDF]

open access: yes, 2017
Alopecia areata is an organ-specific autoimmune disease targeting hair follicles. It causes nonscarring hair loss. The prevalence rate of the disease is approximately 1 in 1000 people worldwide.
Engin, Burhan   +2 more
core   +2 more sources

Intestinal Atresia in PPP1R12A ‐Related Urogenital and Brain Malformation Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 12, December 2025.
ABSTRACT PPP1R12A‐related urogenital and brain malformation syndrome (UBMS) is a newly described disorder characterized by congenital anomalies primarily involving the urogenital system and the brain. We describe a preterm female neonate with multiple congenital anomalies, including type IIIb jejunal atresia, incomplete intestinal rotation, imperforate
Adriana Gomes   +4 more
wiley   +1 more source

No Increased Risk of Thromboembolic Events During 6‐Month Treatment With Baricitinib in Patients With Alopecia Areata

open access: yes
International Journal of Dermatology, EarlyView.
Giacomo Caldarola   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy